Delivery Order SPE2DR25D2100-SPE2DR26FA0YN
Award Date 1/2/26
Potential Completion Date 1/5/26
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,679.33 for Quillivant XR 25 mg/5 ml suspension (150 ml) by the Defense Logistics Agency's Medical Supply Chain on September 25, 2025, with completion scheduled for September 26, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on November 4, 2025, for Quillivant XR 25 mg/5 mL suspension in a 120 mL quantity, valued at $2,035.84. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 5, 2025, and represents a pediatric attention-deficit/hyperactivity disorder (ADHD) medication delivery to support...
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,971.30 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml quantities. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on December 11, 2025, for the supply of Quillivant XR oral suspension (60mL, 5mg/mL) with a ceiling value of $5,050.34. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 12,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on June 18, 2025, valued at $1,597.18 for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml). The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 20, 2025. Performance will occur at the vendor's corporate office location in Conshohocken, PA. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $4,254.29 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension in a 180 ml quantity. The award was made on April 23, 2025, with an ultimate completion date of April 24, 2025, utilizing firm fixed price pricing. This non-set-aside contract was competitively awarded to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a $1,030.10 delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (180 ml), with an ultimate completion date of December 11, 2025. This is a firm fixed-price, non-set-aside contract utilizing a competitive award process. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive portfolio of medications and medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,336.72 to AmerisourceBergen Drug Corp for the supply of Quillivant XR oral suspension 60ml 5mg/ml, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and represents a pharmaceutical supply transaction typical of federal medical procurement operations. The work is to be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,978.37 for Quillivant XR 25 mg/5 ml suspension (60 ml) with a firm fixed price structure. This non-set-aside, competitively awarded contract was executed on September 9, 2025, with an ultimate completion date of September 10, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 20, 2025, for the supply of Quillivant XR Oral Suspension 60ML 5MG/ML with a ceiling value of $1,203.08. This is a firm fixed-price, non-set-aside competitive award issued by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of October 21, 2025. The delivery will be performed at the awardee's corporate office...